Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Evidence suggests patients on low-carb diets achieve type 2 diabetes remission
Patients with diabetes who consistently followed a low-carbohydrate diet for 6 months achieved a higher rate of remission — 32% — compared with mostly low-fat diets, according to a systematic review and meta-analysis.
Diabetes complications differ according to ethnicity, disease-related subgroups
Risks for diabetes complications vary according to subgroups related to age of onset, HbA1c, obesity and insulin use, and there are racial and ethnic disparities in the composition of each subgroup, according to study data.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants priority review to diabetic kidney disease treatment from Bayer
The FDA has granted priority review to a new drug application for finerenone, a non-steroidal mineralocorticoid receptor inhibitor antagonist, for the treatment of diabetic kidney disease.
SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs
For patients with type 2 diabetes, SGLT2 inhibitors conferred a lower risk of developing AKI than use of GLP-1 receptor agonists or dipeptidyl peptidase-4 inhibitors, according to a network meta-analysis of clinical trials.
‘Relatively high proportion’ of patients with diabetes experience rapid CKD progression
Approximately 10% to 17% of patients with type 2 diabetes and newly identified chronic kidney disease had their condition worsen within 2 years, according to a study published in the Clinical Kidney Journal.
Statins for primary prevention associated with CV benefit in older adults
Statin use for primary prevention was associated with CV benefits in older adults, without significant risk for development of new-onset diabetes, according to research published in the American Journal of Medicine.
Spinal cord stimulators provide relief from diabetic neuropathic pain
An implanted 10 kHz spinal cord stimulator, when used in tandem with opioids and other pain relievers, provided patients relief from diabetic neuropathic pain, data show.
Diabetes Awareness Month: 10 updates on its detection, risks, management
Diabetes reduces life expectancy in middle-aged adults by up to 10 years and independently increases the risk for death from cancer, CVD and renal disease as much as threefold, according to the Lancet Commission on diabetes.
Hypertension, diabetes ‘common’ in patients with neurological complications of COVID-19
Among patients with COVID-19, those who had hypertension or type 2 diabetes were more likely to develop neurological conditions associated with the infectious disease, data from a small study show.
SCORED/SOLOIST: Dual SGLT inhibitor shows new CV benefits in type 2 diabetes
Adults with type 2 diabetes and worsening HF or at CV risk assigned the dual SGLT1/SGLT2 inhibitor sotagliflozin saw reduced risk for CV death and hospitalization or urgent visits for HF compared with placebo.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read